Cargando…

Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma

Introduction: The emerging field of “radiomics” has considerable potential in disease diagnosis, pathologic grading, prognosis evaluation, and prediction of treatment response. We aimed to develop a novel radiomics nomogram based on radiomics features and clinical characteristics that could preopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenjie, Xu, Lei, Yang, Pengfei, Zhang, Lele, Wan, Dalong, Huang, Qiang, Niu, Tianye, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131601/
https://www.ncbi.nlm.nih.gov/pubmed/30234019
http://dx.doi.org/10.3389/fonc.2018.00360
_version_ 1783354146583216128
author Liang, Wenjie
Xu, Lei
Yang, Pengfei
Zhang, Lele
Wan, Dalong
Huang, Qiang
Niu, Tianye
Chen, Feng
author_facet Liang, Wenjie
Xu, Lei
Yang, Pengfei
Zhang, Lele
Wan, Dalong
Huang, Qiang
Niu, Tianye
Chen, Feng
author_sort Liang, Wenjie
collection PubMed
description Introduction: The emerging field of “radiomics” has considerable potential in disease diagnosis, pathologic grading, prognosis evaluation, and prediction of treatment response. We aimed to develop a novel radiomics nomogram based on radiomics features and clinical characteristics that could preoperatively predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICC) after partial hepatectomy. Methods: A predictive model was developed from a training cohort comprising 139 ICC patients diagnosed between January 2010 and June 2014. Radiomics features were extracted from arterial-phase image of contrast-enhanced magnetic resonance imaging. Feature selection and construction of a “radiomics signature” were through Spearman's rank correlation and least absolute shrinkage and selection operator (LASSO) logistic regression. Combined with clinical characteristics, a radiomics nomogram was developed with multivariable logistic regression. Performance of the nomogram was evaluated with regard to discrimination, calibration, and clinical utility. An independent validation cohort involving 70 patients recruited from July 2014 to March 2016 was used to evaluate the utility of the nomogram developed. Results: The radiomics signature, consisting of nine features, differed significantly between ER patients and non-ER patients in training and validation cohorts. The area under the curve (AUC) of the radiomics signature in training and validation cohorts was 0.82 (confidence interval [CI], 0.74–0.88) and 0.77 (95% CI, 0.65–0.86), respectively. The AUC of the radiomics nomogram combining the radiomics signature and clinical stage in the two cohorts was 0.90 (95%CI, 0.83–0.94) and 0.86 (95% CI, 0.76–0.93), respectively. Decision curve analysis confirmed the clinical usefulness of the radiomics nomogram. Conclusion: The non-invasive radiomics nomogram developed using the radiomics signature and clinical stage could be used to predict ER of ICC after partial hepatectomy.
format Online
Article
Text
id pubmed-6131601
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61316012018-09-19 Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma Liang, Wenjie Xu, Lei Yang, Pengfei Zhang, Lele Wan, Dalong Huang, Qiang Niu, Tianye Chen, Feng Front Oncol Oncology Introduction: The emerging field of “radiomics” has considerable potential in disease diagnosis, pathologic grading, prognosis evaluation, and prediction of treatment response. We aimed to develop a novel radiomics nomogram based on radiomics features and clinical characteristics that could preoperatively predict early recurrence (ER) of intrahepatic cholangiocarcinoma (ICC) after partial hepatectomy. Methods: A predictive model was developed from a training cohort comprising 139 ICC patients diagnosed between January 2010 and June 2014. Radiomics features were extracted from arterial-phase image of contrast-enhanced magnetic resonance imaging. Feature selection and construction of a “radiomics signature” were through Spearman's rank correlation and least absolute shrinkage and selection operator (LASSO) logistic regression. Combined with clinical characteristics, a radiomics nomogram was developed with multivariable logistic regression. Performance of the nomogram was evaluated with regard to discrimination, calibration, and clinical utility. An independent validation cohort involving 70 patients recruited from July 2014 to March 2016 was used to evaluate the utility of the nomogram developed. Results: The radiomics signature, consisting of nine features, differed significantly between ER patients and non-ER patients in training and validation cohorts. The area under the curve (AUC) of the radiomics signature in training and validation cohorts was 0.82 (confidence interval [CI], 0.74–0.88) and 0.77 (95% CI, 0.65–0.86), respectively. The AUC of the radiomics nomogram combining the radiomics signature and clinical stage in the two cohorts was 0.90 (95%CI, 0.83–0.94) and 0.86 (95% CI, 0.76–0.93), respectively. Decision curve analysis confirmed the clinical usefulness of the radiomics nomogram. Conclusion: The non-invasive radiomics nomogram developed using the radiomics signature and clinical stage could be used to predict ER of ICC after partial hepatectomy. Frontiers Media S.A. 2018-09-04 /pmc/articles/PMC6131601/ /pubmed/30234019 http://dx.doi.org/10.3389/fonc.2018.00360 Text en Copyright © 2018 Liang, Xu, Yang, Zhang, Wan, Huang, Niu and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liang, Wenjie
Xu, Lei
Yang, Pengfei
Zhang, Lele
Wan, Dalong
Huang, Qiang
Niu, Tianye
Chen, Feng
Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title_full Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title_fullStr Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title_full_unstemmed Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title_short Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
title_sort novel nomogram for preoperative prediction of early recurrence in intrahepatic cholangiocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131601/
https://www.ncbi.nlm.nih.gov/pubmed/30234019
http://dx.doi.org/10.3389/fonc.2018.00360
work_keys_str_mv AT liangwenjie novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT xulei novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT yangpengfei novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT zhanglele novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT wandalong novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT huangqiang novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT niutianye novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma
AT chenfeng novelnomogramforpreoperativepredictionofearlyrecurrenceinintrahepaticcholangiocarcinoma